BioVoice News eMag November-December 2023 | Page 77

Director of Zydus Healthcare Ltd , Anil was engaged as Senior Advisor – Life Sciences at IQVIA Consulting and Information Services India Pvt . Ltd ., and most recently as Operating Partner at Jashvik Capital – a mid-market Private Equity Fund focused on Healthcare & Consumer sector . Anil has functioned on the boards of Zydus Healthcare Ltd ., Bayer Zydus Pharma Private Ltd ., Novartis Healthcare Private Ltd and Biochem Pharmaceutical Industries Ltd .
Anil Matai said , “ OPPI will continue to drive policy and advocacy discussions with the Government and endeavor to work together with various stakeholders on industry-related issues , to implement sustainable and patient centric solutions .
Kedar Upadhye appointed as new CFO of Biocon Biologics
Kedar Upadhye is appointed as the new Chief Financial Officer ( CFO ) of Biocon Biologics effective 31st October 2023 . He brings with him over 23 years of experience in senior global leadership roles spanning Corporate Finance , Strategy , Accounting , FP & A , Business Finance , Governance and Investor Relations at leading Pharma , Energy and FMCG players such as Cipla , Dr . Reddy ’ s , PepsiCo , and Thermax .
He joins us from ReNew Energy Global Plc , a NASDAQ-listed decarbonization & renewable energy company , where he was the Chief Financial Officer ( CFO ). Prior to ReNew , Kedar was the Global CFO at Cipla where he was instrumental in setting up a strong global finance footprint with a focus on capital allocation , strategic partnership with the business , governance , and risk management in addition to driving the organization towards the next level of growth and delivering a superior return profile . He has a proven track record of overseeing value creation , strengthening investor relations and acting as an enabler of business .
“ I am delighted to welcome Kedar to Biocon Biologics . He joins us at an inflection point in our journey to become a leading global biosimilars company as we look to consolidate and unlock value in the acquired business . I am confident that he will build further on the strong foundation and with his expertise and experience work closely with all stakeholders to drive growth and deliver on our business goals ,” said Shreehas Tambe , CEO & Managing Director , Biocon Biologics .
BIOVOICENEWS . COM 77